Analysed SUMMIT THERAPEUTICS INC (SMMT:NASDAQ) News Sources
Summit Therapeutics shares advance after updated Phase III cancer trial results (NASDAQ:SMMT)
22-07-2026
advfn.com
SMMT Stock Gains After Summit Reports Strong Lung Cancer Survival Results — Investors Await Q2 Earnings
22-07-2026
stocktwits.com
Arcus Biosciences and Summit Therapeutics Enter into Clinical Trial Collaboration to Evaluate Casdatifan Combined with Ivonescimab in Kidney Cancer
22-07-2026
yahoo.com
Did New HARMONi Survival Data Just Shift Summit Therapeutics' (SMMT) Ivonescimab Investment Narrative?
23-07-2026
yahoo.com
Summit Therapeutics Reports Financial Results and Operational Progress for the Second Quarter and Six Months Ended June 30, 2026
23-07-2026
yahoo.com
Summit Therapeutics (SMMT) Updates Phase III Survival Data, Is The Stock Still A Bargain?
24-07-2026
yahoo.com
Summit Therapeutics Inc (SMMT) Q2 2026 Earnings Call Highlights: Strong Cash Position and ...
24-07-2026
yahoo.com
What is the current price of SUMMIT THERAPEUTICS INC (SMMT:NASDAQ)?
The current price of SUMMIT THERAPEUTICS INC (SMMT:NASDAQ) is $13.02.
SUMMIT THERAPEUTICS INC (SMMT:NASDAQ) absolute price change since previous trading day?
The absolute price change of SUMMIT THERAPEUTICS INC (SMMT:NASDAQ) since the previous trading day is $-0.42.
SUMMIT THERAPEUTICS INC (SMMT:NASDAQ) percentage price change since previous trading day?
The percentage price change of SUMMIT THERAPEUTICS INC (SMMT:NASDAQ) since the previous trading day is -3.125%.
What is the most recent average sentiment score for SUMMIT THERAPEUTICS INC (SMMT:NASDAQ)?
The most recent average sentiment score for SUMMIT THERAPEUTICS INC (SMMT:NASDAQ) is 84 out of 100.
What is the most recent average sentiment for SUMMIT THERAPEUTICS INC (SMMT:NASDAQ)?
The most recent sentiment for SUMMIT THERAPEUTICS INC (SMMT:NASDAQ) is .
SEC-8K** Filing Available For SUMMIT THERAPEUTICS INC (SMMT:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.